Professor Antonio Adamo earned his B.S., M.S., and Ph.D. in Medical Biotechnologies and Molecular Medicine from the University of Milan, Italy. He completed postdoctoral fellowships at the Center of Regenerative Medicine in Barcelona, Spain, and the European Institute of Oncology in Milan. In February 2016, he joined KAUST, drawn by its state-of-the-art facilities and collaborative research environment. 

Professor Adamo’s research interests focus on use of human embryonic stem cells (hESCs) and patient-derived induced pluripotent stem cells (iPSCs) to model the onset and progression of human disorders linked to sex chromosome aneuploidies “in a dish.” His team combines reprogramming, brain organoid derivation, and genome editing techniques with a multiomics approach to identify the transcriptional and epigenetic signatures underlying human diseases. His lab has developed extensive cohorts of iPSC lines from patients with sex chromosome aneuploidies, including the first Saudi iPSC cohort, to study the molecular dysregulations associated with X and Y chromosomes overdosage.